Le document Supervision de soutien pendant la COVID-19 s'adresse aux Sociétés nationales de la Croix-Rouge et du Croissant-Rouge. Il est conçu pour leur fournir des conseils pour offrir une supervision de soutien aux volontaires pendant la COVID-19.
Supervisión de apoyo durante la COVID-19 está dirigido a las Sociedades Nacionales de la Cruz Roja y de la Media Luna Roja con el objeto de proporcionar orientaciones sobre cómo ofrecer supervisión de apoyo al voluntariado durante la COVID-19.
French Situation Report on Burkina Faso about Agriculture, Food and Nutrition, IDPs and more; published on 24 Jan 2020 by FEWS NET
Experiences and recommendations from the International Red Cross and Red Crescent Movement.
Measures imposed by governments to prevent the spread of the disease, including lockdown restrictions, quarantines, physical distancing, and their economic and social consequences, further increase this dist...ress and the risk of mental health problems.
more
nContraception and Reproductive Medicine (2017) 2:26 DOI 10.1186/s40834-017-0053-6
Young women in Burkina Faso and Mali are increasingly using modern contraceptives for family planning; however, the LAPM contraceptive prevalence rate remains low. Our analysis indicates that social norms around idea...l family size for both men and women continue to drive young women’s choices around family planning and impede use of LAPMs. To increase modern contraceptive use and curb fertility rates, local governments and development organizations should focus on women’s empowerment and include male partners.
more
Accessed on 20.10.2020
L͛analyse des tendances récentes montre que le Burkina Faso a enregistré une réduction significative de la mortalité infanto-juvénile. Même si aucune des cibles des OMD 4 et 5 n͛a été atteinte par le pays, le taux de mortalité infanto-juvénile est passé de 129 ...pour mille naissances vivantes en 2010 à 82 pour mille naissances
vivantes en 2015, soit une baisse de 7.3% par an. Ceci est en grande partie dû aux progrès enregistrés en matière de lutte contre la mortalité au bénéfice de la tranche juvénile (de 1 à 4 ans). Cependant, comme près de la moitié des enfants âgés de moins de cinq ans continuent de mourir au cours de leur première
année de vie, il reste beaucoup à faire pour l͛atteinte de la vision globale d͛élimination de la mortalité infanto-juvénile évitable et de réduction de la mortalité des mères comme partie prenante des Objectifs de Développement Durable (ODD).
more
Fort de cela, le Burkina Faso a élaboré ce document de stratégie nationale de promotion de la santé (SNPS) pour contribuer à relever les
défis en matière de développement. Son élaboration a suivi un processus participatif, en s'inspirant du guide méthodologique d’élaboration
des polit...iques sectorielles du Burkina Faso[2]. Ils’articule autour des principaux points suivants :
- la mission du secteur de la santé et rappel de la politique nationale de santé ;
- l’analyse de la situation de la promotion de la santé ;
- la vision, les fondements, et les principes directeurs ;
- les objectifs globaux et les orientations stratégiques ;
- les programmes;
- le financement de la stratégie nationale de promotion de la santé ;
- les mécanismes de mise en œuvre, de suivi et d’évaluation.
more
La politique en matière de Santé de la Reproduction définit les grandes orientations
en matière de santé de la reproduction. Elle répond aux questions importantes sur
des thèmes comme les droits en matière de santé de la reproduction, la nature des
services qui doivent être disponibles ...et les règles générales de leur prestation.
La politique de SR sert de référence aux décideurs nationaux et aux partenaires du
développement socio-sanitaire pour la planification et les interventions.
Elle est une composante de la politique sanitaire nationale et un élément de
promotion de la santé des groupes vulnérables que sont entre autres les femmes, les
enfants, les adolescents et les jeunes.
more
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
CYCLE DE PROGRAMMATION HUMANITAIRE 2020-2022
Ce document est consolidé par OCHA pour le compte de l’Équipe humanitaire pays et des partenaires humanitaires. Il présente les priorités et les paramètres de la réponse stratégique de l’Équipe humanitaire pays, basés sur une compréhension ...partagée de la situation.
more
With Safety Tips for Conducting Community Meetings
Updated July 2020
This document includes key Risk Communication and Community Engagement (RCCE) considerations during shifting lockdown measures, safety measures for conducting in-person community meetings, and a template that brings both of these... considerations together to help agencies adapt their RCCE approaches as these measures shift.
more
his practical Guide serves as a companion to the “WHO guideline: recommendations on digital interventions for health system strengthening” and provides a systematic process for countries to develop a costed implementation plan for digital health within one or more health programme areas, drawing... guidance from the WHO guideline–recommended digital health interventions, providing direction to ensure investments are needs-based and contribute effective and interoperable systems aligned with national digital architecture, country readiness, health system and policy goals.
more
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...n this review, 46 therapeutic options are examined. The Pan American Health Organization (PAHO) is continually monitoring ongoing research on any possible therapeutic options. As evidence emerges, then PAHO will immediately assess and update its position, and particularly as it applies to any special sub-group populations such as children, expectant mothers, those with immune conditions, etc.
more
Part 2: Part 2 Beyond the evidence: Implications for innovation and practice
Part 2 of the Gap Analysis presents the insights from individuals working in humanitarian response, disability inclusion and older age inclusion. This report begins by looking at how an agenda for the inclusion of people ...with disability and older people in humanitarian response has been established. The report then considers the ways in which standards and guidance inform humanitarian practice and the challenges associated with translating commitments into practice. Finally, the report identifies seven areas where there are key gaps and opportunities presenting the potential for innovation in research and practice.
more
Children living in humanitarian crises face an increased risk of abuse. While the threats of harm are increasing, the established systems in place to protect them are breaking down. Faced with the COVID-19 pandemic and its impacts, vulnerable families suffer multiple hardships. Schools are closed an...d families have been pushed to the brink of poverty, sometimes having been denied the opportunity to protect and provide for their children.
The report provides an in-depth analysis of 19 Humanitarian Response Plans and Refugee Response Plans from 2019
more
Oсобенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (Covid-19) у детей (clinical guidelines pediatrics)
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...n the context of COVID-19. This includes WHO Priority Medical Devices, specifically: surgical masks, non-surgical masks, gloves, googles, face shields, gowns and N95 masks. It is intended for procurement agencies, occupational health departments, infection prevention and control departments or focal points, health facility administrators, biomedical and materials engineering, PPE manufacturers and public health authorities at both national and facility levels.
more
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline